Delivery Order SPE2DB22D3401-SPE2DB25FT3WH
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,074.51, is for the delivery of Micardis HCT 80-25 mg tablet units over a period ending on May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,217.60, is for the supply of MICARDIS HCT 80-25 mg tablet units with an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $1,318.50 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a period of performance through January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Micardis HCT 80-25 mg tablets. The contract has a firm fixed price of $1,053.14 and a completion date of January 10, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,645.38 firm fixed price contract is for the supply of Micardis HCT 80-25 mg tablets in 30-count units. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.72, is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract is a firm-fixed price delivery order, with a completion date of November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.18, is for the delivery of Micardis HCT 40-12.5 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of June 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,031.77, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of November 13, 2023 and is a firm fixed-price delivery order. There is no set-aside designation indicated. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,047.27 contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a completion date of November 10, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...